A cross over bioequivalence study of losartan H 50/12.5 mg tablet compared to Hyzaar 50/12.5 mg tablet manufactured by Merck in 24 healthy volunteers under fasting condition

Alborz Darou0 个研究点目标入组 24 人开始时间: 待定最近更新: 2022年8月29日

适应症

试验速览

暂无简介。

•Sex: male.Age: 18 - 55 years. . BMI of 18-27 kg/m2 with minimum of 50 kg weight.
•Volunteer willing to adhere to the protocol requirements and to provide written informed consent
•Non-smokers or smoker who smokes less than 10 cigarettes per day

•Clinically relevant abnormalities in the results of the laboratory screening evaluation.
•Systolic blood pressure less than 100 mm Hg or more than 140 mm Hg and diastolic blood pressure less than 60 mm Hg or more than 90 mm Hg.
•Pulse rate less than 50/minute or more than 100/minute.
•History of allergy to the test drug or any drug chemically similar to the drug under investigation.
•History of consumption of prescribed medication since last 14 days or OTC medication since last 07 days before beginning of the study

发起方

Alborz Darou